Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum (Alzheimer's and Dementia, 2019)

(untitled) - Bos, I; Vos, S; Verhey, F; Lovestone, S; Et al.